Metabolic and Lipidomic Markers Differentiate COVID-19 From Non-Hospitalized and Other Intensive Care Patients

SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation

(2021) David W Sanders et al.   eLife

Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis?

(2021) Stefan R. Bornstein et al.   MOLECULAR PSYCHIATRY

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

(2020) Jan Borén et al.   EUROPEAN HEART JOURNAL

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

(2020) Zhe Xu et al.   Lancet Respiratory Medicine

Proteomic and Metabolomic Characterization of COVID-19 Patient Sera

(2020) Bo Shen et al.   CELL

COVID-19 and Multiorgan Response

(2020) Sevim Zaim et al.   CURRENT PROBLEMS IN CARDIOLOGY

Liver injury during highly pathogenic human coronavirus infections

(2020) Ling Xu et al.   LIVER INTERNATIONAL

Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China

(2020) Ling Mao et al.   JAMA Neurology

Management of acute kidney injury in patients with COVID-19

(2020) Claudio Ronco et al.   Lancet Respiratory Medicine

Plasma Metabolomic and Lipidomic Alterations Associated with COVID-19

(2020) Di Wu et al.   National Science Review

COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives

(2020) Masataka Nishiga et al.   Nature Reviews Cardiology

COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status

(2020) Tiffany Thomas et al.   JCI Insight

COVID-19 and the Kidneys: An Update

(2020) Claudia Benedetti et al.   Frontiers in Medicine

Single Virus Targeting Multiple Organs: What We Know and Where We Are Heading?

(2020) Ashish Prasad et al.   Frontiers in Medicine

Integrative Modeling of Quantitative Plasma Lipoprotein, Metabolic, and Amino Acid Data Reveals a Multiorgan Pathological Signature of SARS-CoV-2 Infection

(2020) Torben Kimhofer et al.   JOURNAL OF PROTEOME RESEARCH

SARS-CoV-2 Infection Dysregulates the Metabolomic and Lipidomic Profiles of Serum

(2020) Chiara Bruzzone et al.   iScience

Glycine Metabolism and Its Alterations in Obesity and Metabolic Diseases

(2019) Anaïs Alves et al.   Nutrients

Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease

(2018) Anum Saeed et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver Disease

(2018) Daniele Pastori et al.   Journal of Clinical Medicine

Indications and practical approach to non-invasive ventilation in acute heart failure

(2017) Josep Masip et al.   EUROPEAN HEART JOURNAL

Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies

(2016) Parag H. Joshi et al.   Journal of the American Heart Association

Plasma Glycine and Risk of Acute Myocardial Infarction in Patients With Suspected Stable Angina Pectoris

(2015) Yunpeng Ding et al.   Journal of the American Heart Association

Precision High-Throughput Proton NMR Spectroscopy of Human Urine, Serum, and Plasma for Large-Scale Metabolic Phenotyping

(2014) Anthony C. Dona et al.   ANALYTICAL CHEMISTRY

Triglycerides and cardiovascular disease

(2014) Børge G Nordestgaard et al.   LANCET

MetaboLab - advanced NMR data processing and analysis for metabolomics

(2011) Christian Ludwig et al.   BMC BIOINFORMATICS